Gingiva News and Research RSS Feed - Gingiva News and Research

Oral eosinophilic ulcers ‘a self-limiting, reactive condition’

A review of patients with oral eosinophilic ulcers suggests that the lesions should be considered a reactive, local condition rather than a CD30+ lymphoproliferative disorder. [More]

Blood flow, temperature, reveal relationship between dental implants and healthy teeth

Blood flow in the tissue surrounding dental implants is reduced compared with that found around adjacent natural teeth, and the surface temperature of this implant-associated tissue is higher, show study results. [More]

Oral verrucous lesions need special diagnostic attention

Care should be taken to diagnose oral verrucous lesions accurately according to their nature, behavior, and malignant potential, and should be differentiated from grade I squamous cell carcinoma, suggest Indian researchers. [More]

FDA approves Organogenesis oral soft tissue regeneration product, GINTUIT

Today Organogenesis Inc., a business leader in the regenerative medicine field, announced that the United States Food and Drug Administration (FDA) has approved GINTUIT (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen), a cell-based product that has been shown to predictably generate new and aesthetically appealing oral soft tissue (gum tissue). [More]

Single immediate tooth replacement with tissue graft prevents gum recession

When a tooth is replaced with an implant, receding of the gums can become a concern. This leaves areas of root exposed and can be painful for the patient. While a single tooth replacement performed as an immediate, one-step process is an accepted treatment, gum recession occurs more often with this method of implant. [More]

Organogenesis files a PMA with the FDA for its CelTx living cell-based technology

Organogenesis, Inc. announced today that it has filed a Premarket Approval Application (PMA) with the U.S. Food and Drug Administration (FDA) for its CelTx(TM), a living cellular construct for oral soft tissue regeneration. If approved, CelTx will be the first, living cell-based technology that is FDA-approved for use in the dental market. [More]

Thommen Medical USA launches customizable gingiva former for natural and aesthetic contour

Thommen Medical USA announces the launch of its customizable gingiva former. [More]

Advancement in tissue engineering promotes oral wound healing

Oral tissue engineering for transplantation to aid wound healing in mouth (oral cavity) reconstruction has taken a significant step forward with a Netherlands-based research team's successful development of a gum tissue (gingival) substitute that can be used for reconstruction in the oral cavity. [More]
Tonsil epithelial factors may influence oropharyngeal HIV transmission

Tonsil epithelial factors may influence oropharyngeal HIV transmission

Current research demonstrates that the tonsils may possess the necessary factors to act as a transmission site for the spread of HIV. [More]
Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis

Antibiotics do not prevent recurrent myocardial infarcts in subjects with periodontitis

Periodontitis, an infection of the gingiva and tooth-supporting tissues, may influence the effectiveness of antibiotics used for the prevention of recurrent cardiovascular events. [More]

Clarithromycin reduces recurrent cardiovascular events in patients without periodontitis

Periodontitis, an infection of the gingiva and tooth-supporting tissues, may influence the effectiveness of antibiotics used for the prevention of recurrent cardiovascular events. [More]